Data from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin LymphomaDongwei Li, Andrew G. Polson, Kirsten Achilles Poon et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin LymphomaDongwei Li, Andrew G. Polson, Kirsten Achilles Poon et al.|Unknown|2023Cited by 0
Supplementary Table 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin LymphomaDongwei Li, Andrew G. Polson, Kirsten Achilles Poon et al.|Unknown|2023Cited by 0
Supplementary Table 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin LymphomaDongwei Li, Andrew G. Polson, Kirsten Achilles Poon et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin LymphomaDongwei Li, Andrew G. Polson, Xiaoyan Shi et al.|Unknown|2023Cited by 0